- Ethnomedicinal Study of Plants in Begumganj, Noakhali, Bangladesh
-
Akter KM, Sajib NH, Kang DM, Ahn MJ, Uddin SB
- KMID: 2524101
- Nat Prod Sci.
- 2021 Dec;27(4):217-227.
- doi: 10.20307/nps.2021.27.4.217
This study is a record of ethnomedicinal knowledge in Begumganj province focussed on medicinal plants and their local uses for primary health care. The aim was to document and preserve... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
-
Lee YG, Chang H, Keam B, Chun SH, Park J, Park KU, Shin SH, An HJ, Lee KE, Lee KW, Kim HR, Kim SB, Ahn MJ, Hwang IG
- KMID: 2518390
- Cancer Res Treat.
- 2021 Jul;53(3):671-677.
- doi: 10.4143/crt.2020.824
Purpose This study was conducted to determine the effectiveness of immune checkpoint inhibitors (ICIs) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum-containing chemotherapy. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
-
Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Lee JI
- KMID: 2513858
- J Korean Neurosurg Soc.
- 2021 Mar;64(2):271-281.
- doi: 10.3340/jkns.2020.0135
Objective : Immune checkpoint inhibitors (ICIs) are approved for treating non-small-cell lung cancer (NSCLC); however, the safety and efficacy of combined ICI and Gamma Knife radiosurgery (GKS) treatment remain undefined.... -
- CITED
-
- Close
- SHARE
-
- Close
- Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer
-
Lim SH, Sun JM, Hong J, Oh D, Ahn YC, Chung MK, Jeong HS, Son YI, Ahn MJ, Baek CH, Park K
- KMID: 2513829
- Korean J Intern Med.
- 2021 Mar;36(Suppl 1):S217-S224.
- doi: 10.3904/kjim.2019.161
Background/Aims: Clinical trials have not consistently supported the use of induction chemotherapy (IC) for locally advanced head and neck squamous cell cancer. Hypopharynx and base of tongue (BOT) cancer has... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs
-
Kim KH, Hur JY, Koh J, Cho J, Ku BM, Koh JY, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Shin EC
- KMID: 2511879
- Immune Netw.
- 2020 Dec;20(6):e48.
- doi: 10.4110/in.2020.20.e48
Hyperprogressive disease (HPD) is a distinct pattern of progression characterized by acceleration of tumor growth after treatment with anti-PD-1/PD-L1 Abs. However, the immunological characteristics have not been fully elucidated in... -
- CITED
-
- Close
- SHARE
-
- Close
- EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
-
Park S, Ku BM, Jung HA, Sun JM, Ahn JS, Lee SH, Park K, Ahn MJ
- KMID: 2507954
- Cancer Res Treat.
- 2020 Oct;52(4):1288-1290.
- doi: 10.4143/crt.2020.278
The non-small cell lung cancer with activating epidermal growth factor receptor (EGFR) mutation eventually acquires resistant to either first or second-generation EGFR tyrosine kinase inhibitor (TKI). As the following option,... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
-
Lim SM, Kim SW, Cho BC, Kang JH, Ahn MJ, Kim DW, Kim YC, Lee JS, Lee JS, Lee SY, Park KU, An HJ, Cho EK, Jang TW, Kim BS, Kim JH, Lee SS, Na II, Yoo SS, Lee KH
- KMID: 2507937
- Cancer Res Treat.
- 2020 Oct;52(4):1112-1119.
- doi: 10.4143/crt.2020.245
Purpose The introduction of immune checkpoint inhibitors represents a major advance in the treatment of lung cancer, allowing sustained recovery in a significant proportion of patients. Nivolumab is a monoclonal anti–programmed... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Helicobacter pylori Activity of Compounds Isolated from Fraxinus mandshurica Bark
-
Akter KM, Kim HJ, Park WS, Khalil AAK, Ahn MJ
- KMID: 2507473
- Nat Prod Sci.
- 2020 Jun;26(2):158-164.
- doi: 10.20307/nps.2020.26.2.158
Helicobacter pylori is a well-known pathogen that is responsible for gastric disorders. Overcoming of the antibiotic-resistance is a main barrier to treat H. pylori infection. In our search for anti-H.... -
- CITED
-
- Close
- SHARE
-
- Close
- The Interrater Agreement for the Assessment of Pressure Ulcer Risk Using the Braden Scale and the Classification of Pressure Ulcers by Nurses in A Medium-Sized Hospital
-
Na HJ, Yoo SH, Kwon YR, Ahn MJ
- KMID: 2471027
- Korean J Adult Nurs.
- 2020 Feb;32(1):35-45.
- doi: 10.7475/kjan.2020.32.1.35
PURPOSE: This methodological study was conducted to evaluate the interrater agreement in pressure ulcer risk assessment using the Braden scale, and in pressure ulcer classification, by nurses in a medium-sized... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms
-
Bang OY, Chung JW, Lee MJ, Seo WK, Kim GM, Ahn MJ, OASIS-Cancer Study Investigators
- KMID: 2500915
- J Stroke.
- 2020 Jan;22(1):1-10.
- doi: 10.5853/jos.2019.02278
Systemic cancer and ischemic stroke are common conditions and two of the most frequent causes of death among the elderly. The association between cancer and stroke has been reported worldwide.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea
-
Lee K, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2501221
- Cancer Res Treat.
- 2020 Jan;52(1):292-300.
- doi: 10.4143/crt.2019.186
Purpose Human epidermal growth factor receptor 2 (HER2) alterations are found in approximately 1%-3% of non-small cell lung cancers (NSCLCs). We evaluated the clinical features and outcomes of NSCLC harboring HER2... -
- CITED
-
- Close
- SHARE
-
- Close
- Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
-
Ahn MJ, Han JY, Kim DW, Cho BC, Kang JH, Kim SW, Yang JCH, Mitsudomi , Lee JS
- KMID: 2501220
- Cancer Res Treat.
- 2020 Jan;52(1):284-291.
- doi: 10.4143/crt.2019.200
Purpose Osimertinib is a third-generation, irreversible, oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that potently and selectively inhibits both EGFR sensitizing mutation and EGFR T790M and has demonstrated... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmaceutical Studies on “Dang-Gui†in Korean Journals
-
Ahn J, Ahn MJ, Chin YW, Kim J
- KMID: 2468060
- Nat Prod Sci.
- 2019 Dec;25(4):285-292.
- doi: 10.20307/nps.2019.25.4.285
A crude drug “Dang-Guiâ€, belonging to the genus Angelica, has been used as a traditional herbal medicine in Asia. Various studies have investigated the chemical components and pharmacological activities of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
-
Kim MJ, Kim SM, Jung HA, Hong JY, Chang WJ, Choi MK, Kim HS, Sun JM, Park K, Ahn MJ
- KMID: 2457034
- Korean J Intern Med.
- 2019 Sep;34(5):1107-1115.
- doi: 10.3904/kjim.2017.234
BACKGROUND/AIMS: We investigated the efficacy and toxicity of a weekly schedule of docetaxel and cisplatin as a first-line treatment in patients with recurrent or metastatic head and neck squamous cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Purpurogallin Protects Keratinocytes from Damage and Apoptosis Induced by Ultraviolet B Radiation and Particulate Matter 2.5
-
Zhen AX, Piao MJ, Hyun YJ, Kang KA, Ryu YS, Cho SJ, Kang HK, Koh YS, Ahn MJ, Kim TH, Hyun JW
- KMID: 2455095
- Biomol Ther.
- 2019 Jul;27(4):395-403.
- doi: 10.4062/biomolther.2018.151
Purpurogallin, a natural phenol obtained from oak nutgalls, has been shown to possess antioxidant, anticancer, and anti-inflammatory effects. Recently, in addition to ultraviolet B (UVB) radiation that induces cell apoptosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology of Legionella and Climatic Variables in Seoul, Korea
-
Park SH, Jin YH, Ahn MJ, Han SH, Kim HS, Kim JS, Park JH, Hong CK, Park SY, Oh AR, Lee JH, Kim IY, Shin YS
- KMID: 2452047
- J Bacteriol Virol.
- 2019 Jun;49(2):59-68.
- doi: 10.4167/jbv.2019.49.2.59
Legionella species are abundant in the built environment and are increasingly recognized as a cause of Legionnaires' disease (LD). As the number of cases of Legionnaires' disease acquired by local... -
- CITED
-
- Close
- SHARE
-
- Close
- Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
-
Lee KH, Ahn YC, Pyo H, Noh JM, Park SG, Kim TG, Lee E, Nam H, Lee H, Sun JM, Ahn JS, Ahn MJ, Park K
- KMID: 2464422
- Cancer Res Treat.
- 2019 Apr;51(2):769-776.
- doi: 10.4143/crt.2018.366
PURPOSE: This study is to report clinical outcomes of salvage concurrent chemo-radiation therapy (CCRT) in treating patients with loco-regional recurrence (LRR) following initial complete resection of non-small cell lung cancer. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
-
Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, Cho EK, Choi YH, Kim HR, Kim HG, Ahn HJ, Lee HY, Yun HJ, Kang JH, Jeong J, Choi MY, Jung SH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2464417
- Cancer Res Treat.
- 2019 Apr;51(2):718-726.
- doi: 10.4143/crt.2018.324
PURPOSE: The optimal cytotoxic regimens have not been established for patients with non-small cell lung cancer (NSCLC) who develop disease progression on first-line epidermal growth factor receptor tyrosine kinase inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
-
Byeon S, Kim Y, Lim SW, Cho JH, Park S, Lee J, Sun JM, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2464409
- Cancer Res Treat.
- 2019 Apr;51(2):623-631.
- doi: 10.4143/crt.2018.151
PURPOSE: Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for approximately 4% of all EGFR mutations. Given the rarity of this mutation, its clinical outcomes are not fully... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
-
Kim Y, Lee SH, Ahn JS, Ahn MJ, Park K, Sun JM
- KMID: 2464397
- Cancer Res Treat.
- 2019 Apr;51(2):502-509.
- doi: 10.4143/crt.2018.117
PURPOSE: We tried to evaluate whether there are any specific features in treatment outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC),... -
- CITED
-
- Close
- SHARE
-
- Close
